An understanding of the basic mechanisms responsible for the pathogenesis of liver neoplasms is needed in order to develop better therapeutic strategies. The present study utilized a pharmacogenetic mouse model to assess the role of cytochrome P4501A1 (Cyp1a1) in modulating genetic damage to oncogenic and tumor suppressor loci following in utero exposure to the polycyclic aromatic hydrocarbon, 3-methylcholanthrene (MC). Analysis of the Ha-ras, Kiras, INK4a and p53 genes was carried out with lysates from paraffin-embedded liver tissue from transplacentallytreated mice. The lysates were subjected to DNA amplification by the PCR technique followed by allele-specific oligonucleotide hybridization screening and SSCP analysis. All of the 26 neoplasms screened (23 hepatocellular carcinomas, two hepatocellular adenomas and one sarcoma) exhibited a GGC→CGC (GLY 13 *Abbreviations: ASO, allele-specific oligonucleotide hybridization; cdk, cyclin-dependent kinase; Cyp1a1, cytochrome P4501A1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MC, 3-methylcholanthrene; PAH, polycyclic aromatic hydrocarbon; PCR, polymerase chain reaction; Rb, retinoblastoma; SSCP, single strand conformation polymorphism; SDS, sodium dodecylsulfate; 1ϫ SSC, 0.15 M NaCl/0.015 M sodium citrate (pH 7.0); BPB, bromophenol blue; 1ϫ TBE, 100 mM Tris-HCL/90 mM boric acid/ 1 mM EDTA.
Introduction
The molecular mechanisms that govern tumorigenesis involve both genetic and environmental factors. The unique qualities of the gestating organism render it particularly sensitive to the complex interplay of these variables, as studies by this and other laboratories have demonstrated the high sensitivity of the embryo and fetus to the toxic and carcinogenic effects of environmental chemicals following in utero exposures (1) (2) (3) (4) . A direct link between maternal exposure to environmental carcinogens and an increased incidence of childhood, as well as adult, cancer has been reported by several groups (5-7). In particular, these studies have demonstrated an increased childhood cancer risk when the mother smoked. Cigarette smoke constituents, such as polycyclic aromatic hydrocarbons (PAHs*), have been shown to readily cross over the placental membrane (8) and induce fetal cytochrome P450 metabolizing enzymes (9) . The induction of these enzymes has consistently shown to be positively correlated with cancer risk (10) . PAH-DNA adducts have been detected in placental DNA from more smokers than non-smokers, and when the adducts were present, there was higher aryl hydrocarbon hydroxylase activity (11) (12) (13) . The carcinogenic effects of transplacental exposure to PAHs has been documented by several laboratories in a variety of species (14, 15) , starting with the early studies by Tomatis et al., who showed that mice exposed in utero to 3-methylcholanthrene (MC) developed lung tumors and lymphomas (16) . More recent studies that utilized the pharmacogenetic model have been reported by Anderson et al. (15) and Wessner and colleagues (17) . These findings provide evidence that transplacental exposure to environmental toxicants such as PAHs and the subsequent induction of P450 enzymes may play important roles in the initiation of tumors.
As a multistep process, tumor formation appears to involve the accumulation of aberrations in specific gene products important for normal cell growth and differentiation (18) . In addition, accumulating evidence from studies conducted with both human and experimentally-induced rodent tumors have provided a direct connection between alterations in cell cycle regulatory genes and neoplasia (19) . Proto-oncogenes involved in cell proliferation, and tumor suppressor genes involved in growth arrest and apoptosis, appear to play important roles in cell homeostasis. Deregulation of these regulatory pathways, as a consequence of a mutation and/or altered expression in one or more of these genes, can result in the formation of tumors. Alterations within proto-oncogenes and tumor suppressor genes have been reported to be among the most prevalent genetic lesions in human tumors (20) (21) (22) .
Among the most frequently altered proto-oncogenes in both human and experimentally-induced rodent tumors are members of the ras gene family (20) . The Ha-, N-and Ki-ras genes ordinarily behave as relay switches within the signal transduction pathway by regulating the transduction of signals from the surface of cells to intracellular targets. When oncogenically activated, Ras loses its intrinsic GTPase activity, resulting in GTP being constitutively bound to Ras. The resultant continuous propagation of growth signals contribute ultimately to the formation of tumors. Approximately 30% of all human tumors harbor a mutated ras gene, and up to 95% of human pancreatic cancers are associated with ras gene mutations (23) .
Tumor suppressor genes, such as p53 and INK4a, have also been shown to play a role in the neoplastic process. In particular, these genes have been shown to negatively regulate cellular proliferation and their inactivation can result in the loss of a crucial 'brake' on tumor growth (18) . The p53 gene product, in particular, plays an important role in the maintenance of the genomic integrity of the cell and is often regarded as the guardian of the genome (24) . In response to DNA damage, the p53 gene induces either apoptosis or growth arrest in the G1 phase of the cell cycle (25) . The inactivation of this gene can, therefore, result in the accumulation of mutations within the genome. Several human cancers have been shown to harbor an inactivated p53 gene. Alterations in p53 have been found to occur in 50% of all human cancers (26) , which represents the most common genetic change in cancer cells (27) .
A vast amount of data have also accumulated that implicate the loss of INK4a function in the development of a wide spectrum of tumors (28) . As a tumor suppressor gene, INK4a negatively regulates the transition of cells through the G1 phase of the cell cycle by binding to cyclin-dependent kinase (cdk) 4 and/or 6. The binding of INK4a to these kinases prevents the formation of cyclin D1/cdk4 and/or cdk6 complexes and inhibits the phosphorylation of the retinoblastoma (Rb) gene. The hypophosphorylated form of the Rb protein binds and sequesters the E2F family of transcription factors, which prevents the transcription of genes that promote entry of cells into S phase (29) . Accordingly, molecular alterations in the INK4a gene can result in an unchecked increase in cell proliferation. Recent evidence shows that the incidence of mutations in this gene and its involvement in cancer is probably second only to the p53 gene (19) .
A pharmacogenetic mouse model (reviewed in 3) has been utilized by this laboratory as a means of gaining a clearer understanding of the influence of hereditary and environmental factors on tumor formation following in utero exposure to the model polycyclic aromatic hydrocarbon, MC. The level of expression of cytochrome P4501A1 (Cyp1a1) has been demonstrated to influence the incidence of lung and liver tumors in mice (17, 30) . The mouse model used in the present study will help clarify the role in which these enzymes play in the formation of mouse liver tumors. The development of hepatocellular neoplasms, in both humans and experimental animals, has been shown to involve the accumulation of aberrations in known and putative proto-oncogenes and tumor suppressor genes (31) . However, little work has been done to determine the molecular pathogenesis of liver tumors induced following in utero exposure to environmental toxicants. We utilized tissue from a previous study (17) to assess the underlying genetic lesions responsible for liver tumor formation following transplacental exposure to MC. 3Ј primer 5Ј-AAAGTGGTTCTGGATCAG-3Ј exon 2 5Ј primer 5Ј-GACTCCTACCGGAAACAG-3Ј 3Ј primer 5Ј-GTGCGCATGTACTGGTCCCG-3Ј Ki-ras exon 1 5Ј primer 5Ј-ATGACTGAGTATAAACTTGT-3Ј
Materials and methods

Chemicals
3Ј primer 5Ј-TCGTACTCATCCACAAAGTG-3Ј INK4a exon 1 5Ј primer 5Ј-GGTCACACGACTGGGCGATT-3Ј
3Ј primer 5Ј-GAATCGGGGTACGACCGAAA-3Ј exon 2 5Ј primer 5Ј-GTGATGATGATGGGCAACGT-3Ј
3Ј primer 5Ј-GGGCGTGCTTGAGCTGAAGC-3Ј p53 exon 5 5Ј primer 5Ј-ACACCTGATCGTTACTCGGCTTGTC-3Ј 3Ј primer 5Ј-GGAGGAGCCAGGCCTAAGAGCAA-3Ј exon 6 5Ј primer 5Ј-CACCATGAGCGCTGCTCCGATGG-3Ј
3Ј primer 5Ј-GCTAGAAAGTCAACATCAGTCTAGG-3Ј exon 7 5Ј primer 5Ј-CAGGTCACCTGTAGTGAGGTAGGG-3Ј
3Ј primer 5Ј-TGGAACAGAAACAGGCAGAAGCTGG-3Ј exon 8 5Ј primer 5Ј-AGTCAGGATGGGGCCCAGCTTTCT-3Ј
3Ј primer 5Ј-AAGAGGTGACTTTGGGGTGAAGCTC-3Ј
Amplification conditions are listed in Materials and methods.
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Animals and treatment protocol
Paraffin-embedded liver tissue was generated from a previous study (17) . B6D2F1 mice, phenotypically responsive and genotypically heterozygous for the aryl hydrocarbon receptor gene, were mated with non-responsive DBA females, which resulted in a litter in which half the fetuses had the responsive phenotype and half the non-responsive phenotype. On day 17 of gestation (day 1 being the day the vaginal plug was first detected), pregnant females were treated with a single i.p. injection of either 0.5 ml/35 g olive oil or 30 mg/kg of MC dissolved in olive oil. The offspring were born 3 days later and were foster-nursed by untreated mothers to avoid further carcinogen exposure through the mother's milk. The mice were housed for 1 year with no further treatments, at which time they received a 120 mg/kg dose of β-naphthoflavone and were killed by cervical dislocation 24 h later. Visible liver tumors were removed, fixed and embedded into paraffin blocks. Standard hematoxylin and eosin stained slides were evaluated to determine the type and stage of the liver tumors. Of the phenotypically responsive male offspring exposed in utero to MC, 63% (10/16) exhibited macroscopically visible liver tumors, while 35% (7/20) of the non-responsive male mice exhibited liver tumors (17) . Liver sections were examined by a board-certified veterinary pathologist using standard histopathologic criteria (32) . Tumors were histologically classified as one sarcoma, two hepatocellular adenomas and 23 hepatocellular carcinomas.
Extraction and amplification of paraffin-embedded liver tissue
Small sections of paraffin-embedded liver tissue from 26 tumors and two oiltreated control mice were cut from the paraffin blocks with a clean razor blade. The sections were deparaffinized with two rounds of xylene incubations for 30 min at room temperature, followed by two rinses with 100% ethanol. The samples were dried in a vacuum desiccator and incubated overnight at 37°C in digestion buffer (50 mM Tris-HCl pH 8.0/0.1 mM EDTA/0.5% Tween 20) containing 150-200 µg/ml of Proteinase K. The Proteinase K was inactivated by incubation at 95°C for 8 min (33). A 2 µl aliquot of the lysate was then subjected to the polymerase chain reaction (PCR) using the Perkin-Elmer GeneAmp PCR Reagent Kit. All reactions were carried out in 100 µl and consisted of reaction buffer (10 mM Tris-HCl, pH 8.0/2.5 mM MgCl 2 /50 mM KCl), 200 µM dNTPs (dATP, dCTP, dGTP, dTTP) and 2 units of AmpliTaq Gold (Perkin-Elmer). For amplification of Ha-ras, the Mg concentration was adjusted to 4.0 mM. Primers for the Haras, Ki-ras, p53 (Oligos Etc., Guilford, CT), and INK4a (DNA Synthesis Core Laboratory, Comprehensive Cancer Center of Wake Forest University) genes were added at a final concentration of 0.2 µM for each primer (Table I) . The samples were overlaid with 100 µl of mineral oil to prevent evaporation and cross-contamination of the samples. Amplification conditions of exons 1 and 2 of the Ha-ras gene and exons 1 and 2 of INK4a consisted of an initial denaturation step of 94°C for 2 min, followed by 40 successive cycles of 1 min at 94°C (denaturing), 2 min at 58°C (annealing) and 2 min at 72°C (extension), with a final extension step of 72°C for 7 min. Conditions of exon 1 of the Ki-ras gene consisted of an initial 2-min denaturation step at 94°C, followed by 40 cycles of 1 min at 94°C, 2 min at 50°C, and 2 min at 74°C, with a final extension step of 74°C for 7 min. Exons 5, 6, 7 and 8 of the p53 gene were amplified via an initial 2 min denaturation step at 94°C, followed by 40 cycles of 94°C for 1 min and 65°C for 3 min, with a 7 min final extension step at 72°C. Each amplification reaction included procedure controls (PC), which were taken through the entire experimental protocol to check for cross-contamination. Negative controls (NC) were also included that lacked any template DNA and served as buffer controls. All samples were amplified in an Ericomp DeltaCycler II System.
Allele-specific oligonucleotide hybridization (ASO)
Aliquots of 30 µl of the PCR products, diluted in 170 µl of sterile water, were heat denatured and blotted directly onto a Nytran membrane filter (Schleicher & Schuell, Keene, NH) using a Schleicher & Schuell minifold II slot blot apparatus. The amplified DNA products were fixed to the membrane by UV cross-linking and screened with 5Ј-end-labeled 20 base pair oligonucleotides to the 12th, 13th and 61st codons of the mouse Ha-ras gene (Integrated DNA Technologies, Coralville, IA), as well as the 12th and 13th codons of the mouse Ki-ras gene (Clontech, Palo Alto, CA). The filters were prehybridized in oligonucleotide buffer at 37°C for~2.5 h. Following the addition of an oligomer that was 5Ј-end-labeled with γ-32 P (5ϫ10 6 c.p.m./ml), the membrane was hybridized for 12 to 16 h and the filters then washed under stringent conditions (3°C below the T M ) allowed only fully matched probes to remain bound to the DNA (34) . The blots were then visualized on a Molecular Dynamics Phosphorimager 445SI (Sunnyvale, CA).
Single-strand conformation polymorphism analysis (SSCP)
A second round of PCR reactions was performed with 2 µl of PCR products from the initial PCR reaction using the same amplimers. The amplimers were 5Ј-end-labeled with [γ-32 P]ATP, added to a 20 µl PCR mixture, and amplified as described above except that the annealing/elongation step of the p53 amplification reaction was reduced to 2 min, and the annealing and elongation steps of INK4a amplification were each reduced to 1 min. The number of cycles was also reduced to 20 for both genes. Aliquots of 4 µl of the radioactive PCR products were added to 40 µl of stop buffer (95% formamide/ 10 mM NaOH/0.025% BPB/0.025% xylene cyanol), heat denatured for 5 min at 95°C, and then chilled on ice. Aliquots of 4 µl of this mixture were electrophoresed under varying conditions in 0.6ϫ TBE running buffer (60 mM Tris-HCl/54 mM boric acid/0.6 mM EDTA). Exon 1 of the INK4a gene was separated on a non-denaturing 0.5ϫ MDE gel (FMC Bioproducts, Rockland, ME) in the presence of 5% glycerol at 4°C for 9.5 h at 9 W, and in the absence of glycerol at 4°C for 7.5 h at 9 W. Exon 2 of the INK4a gene was separated on a 0.5ϫ MDE gel in the presence of 5% glycerol at room temperature for 12 h at 10 W, and in the absence of glycerol at room temperature for 9.5 h at 10 W. p53 Exons 5, 6, 7 and 8 were separated on a 0.5ϫ MDE gel in the presence of 5% glycerol at 4°C for 5 h at 35 W, and in the absence of glycerol at 4°C for 4 h at 25 W. The gels were vacuum dried and placed on Kodak film for overnight exposure.
Sequence analysis
The developed film was aligned with the dried SSCP gel and shifted bands from exon 1 of INK4a and exons 5-8 of p53 were excised using clean razor blades. Each band was placed in 100 µl of nuclease-free water and heated to 80°C for 15 min. Aliquots of 30 µl of template were amplified following the same procedures and under the same conditions used for the initial PCR amplification reactions, except that the number of cycles was reduced to 30. The DNA was purified from a low melting point agarose gel and cloned using the TA Cloning Kit (Invitrogen Corp., San Diego, CA) according to the manufacturer's instructions. Briefly, the gel purified products were ligated into pCRII cloning vectors and used to transform Escherichia coli. Plasmid DNA was isolated from transformed colonies using Qiagen columns (Qiagen Inc., Chatsworth, CA) and sequenced using the ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City, CA) according to the manufacturer's instructions. Shifted bands from a SSCP gel were also used in the sequence analysis of exon 2 of the INK4a gene. Aliquots of 30 µl of template were amplified following the conditions stated above, followed by direct automated sequencing of the PCR product. The Ki-ras gene was sequenced directly from the initial PCR products using the ABI PRISM sequencing kit. Analysis of the DNA sequences was done using the DNASIS software (Hitachi Software Engineering America, Ltd, San Bruno, CA).
RNA blot analysis
Liver tissue RNA was purified using the standard guanidine isothiocyanate/ CsCl density centrifugation method (35) . The RNA was dissolved in 10 mM sodium phosphate, denatured with 1 M glyoxal, and either directly blotted to a Nytran membrane using the Minifold II slot blot apparatus (Schleicher & Schuell, Keene, NH) or first fractionated on a 1% agarose gel and then transferred to a nylon membrane. The blots were UV cross-linked, boiled in 1047 10 mM Tris-HCl (pH 8.0) to remove the glyoxal, and then prehybridized at 42°C for 2 h in 50% formamide/5ϫ SSC (pH 7.0)/5ϫ Denhardt's solution/ 50 mM sodium phosphate (pH 7.0)/250 µg/ml salmon sperm DNA/0.1% sodium dodecylsulfate (SDS). Plasmids were labeled with [α-32 P]dCTP using the Multiprime DNA labeling system (Amersham, Arlington Heights, IL) to a specific activity Ͼ10 8 c.p.m./µg. A final concentration of 3 ng/ml of the probe was added to fresh hybridization solution containing 5% dextran sulfate and the blots were hybridized overnight at 42°C. The blots were then washed 2ϫ for 10 min with 2ϫ SSC/0.1% SDS at room temperature, followed by three washes at 50°C for 20 min each with 0.1ϫ SSC/0.1% SDS. The blots were visualized on a 445SI Phosphorimager and analyzed using the Image Quant software (Molecular Dynamics, Sunnyvale, CA).
Liver tissues from oil-treated mice were used as controls, which were corrected for GAPDH expression. Tumor and control tissue samples were hybridized, probed and stripped multiple times on the same blot. The relative absorbance values for each probe were corrected using the level of expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts. The blots were probed with the following plasmids: RSV-cj, a cDNA of the human cjun gene (36) 
Results
Previous results from this laboratory that utilized transplacental treatment of pregnant mice with MC demonstrated the important role that hereditary and environmental factors play in lung tumor formation, as well as some of the molecular aberrations involved in lung carcinogenesis (17, 44) . The present study sought to determine the molecular pathogenesis of liver tumors found in these same mice, as alterations in both protooncogenes and tumor suppressor genes have been shown to play an important role in the development of liver neoplasms (31) . Analyses of the proto-oncogenes Ha-ras and Ki-ras, and the tumor suppressor genes INK4a and p53, were carried out with lysates from paraffin-embedded liver tissue from transplacentally-treated male mice. The lysates were subjected to DNA amplification followed by allele-specific oligonucleotide hybridization screening or SSCP analysis for the presence of point mutations.
Amino acid substitutions at codons 12, 13 and 61 of the Ha-ras gene are frequently mutated in experimental rodent liver cancer bioassays (31,45), thus we initially screened the Ha-ras gene for the presence of mutations using 20 bp oligonucleotide probes. Each codon was screened with six different mutant oligomers differing from the wild-type sequence by 1 bp. Binding to the wild-type sequence was observed in all samples (not shown). Despite the well-documented role that activated Ha-ras plays in murine liver neoplasia, ASO analysis of codons 12, 13 and 61 of the Haras gene did not reveal any mutations.
Because of the lack of mutations in Ha-ras and the prevalence of Ki-ras mutations in human tumors (46) and in the lung tumors isolated from these mice (17, 44) , PCR and ASO analyses were next performed on this gene. Figure 1 shows the results of an ASO analysis of the Ki-ras gene. As can be seen, all of the PCR products from normal and tumor tissue hybridized to the wild-type GLY 13 probe. In addition, all of the 26 liver neoplasms screened exhibited a GGC→CGC (GLY 13 →ARG 13 ) transversion in exon 1 of the Ki-ras gene locus. To ensure that the results were not caused by Taqinduced errors during primary amplification, four separate amplification reactions and ASO analyses were performed with each sample, along with the appropriate positive and negative controls. Tumors were considered positive for mutations only if they exhibited a positive signal in all of the ASO reactions. Five randomly chosen PCR products from four mouse tumors, and normal tissue from an oil-treated control mouse, were then subjected to automated sequencing to further confirm the presence of the transversions at codon 13. All four samples amplified from MC-induced liver tumor tissue showed the presence of the G→C point mutation, whereas liver tissue from the oil-treated mouse did not. The predominance of guanine mutations is consistent with the metabolism of MC by Cyp1a1 to reactive electrophiles that bind mainly to guanine bases to form DNA adducts (47) . In contrast to results obtained in lung tissue, where the majority of lesions analyzed exhibited a G→T transversion at codon 12 (17, 44) , no Ki-ras mutations were found in codon 12 in liver tumor tissue.
Since all of the tumors exhibited point mutations in the Kiras gene, which plays an important role in signal transduction, a number of growth regulatory gene transcripts were looked at next. Analysis of tumor RNAs showed overexpression in either Ha-ras, cip1 or c-jun in~38% (6/16) of the liver tumor samples (Table II) . The c-myc and c-fos genes exhibited levels comparable with oil-treated control mice, and cyclin D, cyclin E and p53 gene levels were undetectable.
The activation of ras, as shown in the present study, appears to play an important role in liver tumor formation. Likewise, the inactivation of tumor suppressor genes, such as INK4a and p53, has been implicated in liver tumorigenesis. Because of the high prevalence of p53 mutations in human tumors (26), we analyzed liver tumors for alterations at this tumor suppressor Figure 4 , exhibited a CCG→CTG (PRO 73 →LEU 73 ) transition at this gene locus. The band intensities in Figures 2  and 4 varied among liver tumor samples. Some showed the presence of both the wild-type and mutant allele, while other tumor samples appeared to have a complete loss of the wildtype allele. The overall percentage of mouse liver tumors harboring mutations in this tumor suppressor gene was 19% (5/26). As a means of controlling for false positives, each sample was subjected to two separate rounds of primary amplification from lysates, followed by SSCP analysis, cloning, and automated sequencing. Tumors were considered positive for mutations only when identical results were obtained a second time. Further, all isolated clones were sequenced in the forward and reverse directions to further eliminate the possibility of polymerase-induced errors during the sequencing reaction.
In addition to identifying the point mutations, sequence analysis of the murine INK4a gene also revealed an additional GCG (ALA) triplet at codon 11 relative to the sequence reported by Quelle et al. (48) . Normal tissue excised from untreated C57BL/6, DBA/2 and an F2 hybrid also contained this triplet within INK4a. This additional amino acid is also found in the reported human INK4a exon 1 sequence (Genbank accession number L27211) and reported rat INK4a sequence (Genbank accession number L81167) and thus results in a somewhat higher degree of sequence homology between the human, rat and murine INK4a genes (Genbank accession number AF004588). These results have recently been confirmed by Herzog and You (49) .
These combined results indicate that there may be alterations in the structure and/or expression of several different signal transducing molecules that can contribute to the development of malignancy following in utero exposure to environmental toxicants. In particular, the Ki-ras and INK4a genes appear to be critical targets in liver tumorigenesis in this model.
Discussion
The molecular development of hepatocellular carcinomas in both humans and rodents is associated with alterations in known regulatory genes (31) . The data from the present study suggest that Ki-ras activation, combined with INK4a loss, can lead to the formation of liver neoplasms. These findings provide additional clues to the etiology of cancer and the molecular pathogenesis of liver tumor formation.
Ha-ras oncogene activation has been found frequently in mouse liver tumors (31) . However, none of the liver tumors screened for mutations in the present study had activated Haras genes. The lack of mutations at this locus and the preference for mutational activation of Ki-ras by MC in lung tumors from the same mice (17) prompted us to examine the liver tumors for activating mutations at the Ki-ras gene locus.
All of the 26 liver neoplasms screened, regardless of histological type, exhibited a G→C transversion at codon 13 of the Ki-ras gene locus. None of the tumors displayed mutations at codon 12. These findings contrast with the mutational spectrum previously observed in lung lesions from the same mice, which showed a prevalence of G→T transversions predominantly at codon 12 (17, 44) . Thus, treatment with MC resulted in organ-specific differences in the mutational spectrum of the Ki-ras gene. This could be because of the differential expression of various DNA binding proteins or differences in the mechanisms of DNA repair in each organ. While mutations in the three ras genes (Ha-, Ki-and N-ras) have been identified in~30% of all human tumors (20) , the vast majority of these mutations have been shown to occur in the Ki-ras gene. Therefore, the results observed in this mouse model closely resemble that found in human cancer. Exon 2 of Ki-ras was not examined, as all of the tumors exhibited mutations in exon 1 of this gene and double mutations in this gene locus are extremely rare.
Since the ras gene product plays a critical role in signal transduction, a number of growth regulatory gene transcripts were looked at for potential overexpression. These included c-jun, cip1, Ha-ras, c-myc, c-fos, p53, cyclin D and the cyclin E gene. The levels of expression of these transcripts were corrected for the expression of the GAPDH gene, whose expression is regulated in a cell cycle-dependent manner. Analysis of tumor RNAs showed overexpression of c-jun, cip1 or Ha-ras genes in 38% of the tumors. The remaining genes showed neither overexpression or underexpression, but either exhibited expression levels comparable to oil-treated mice or were undetectable. Thus, like human tumors, individual mice exhibit alterations in any one of a number of signal transducing molecules. Whether these are a cause or a consequence of enhanced cell proliferation remains to be determined. These results suggest that mutagenic damage to the Ki-ras gene may be a critical factor mediating transplacentally-induced liver tumorigenesis. The fact that Ki-ras mutations were found in all of the tumors, including the one sarcoma examined, suggests that mutation at this gene locus may be an early event in liver tumor pathogenesis in this model. Several other studies have implicated mutations of members of the ras gene family in the initiation process (50, 51) .
Mutations in both exons 1 and 2 of the INK4a gene were found with~11.5% of the liver tumors exhibiting point mutations in exon 1, and~7.7% of tumors exhibiting point mutations in exon 2. All of the INK4a mutations were C→T or G→A transitions with~67% (4/6) located within CpG dinucleotides. This suggests the possibility that deamination of 5-methylcytosine to thymine may contribute to the malignant disease state (52) . This most likely occurs during tumor progression, and is possibly the result of a ras-driven increase in cell proliferation. Both Fan and Bertino (53) and Serrano et al. (54) have proposed a model in which activation of ras genes is the first step in the neoplastic process. Their model suggests that mutagenic activation of Ras produces a constitutive mitogenic signal, which results in increased cell prolifera-tion. However, the inappropriate growth signal by oncogenic Ras would also cause an increase in apoptosis. Thus, inactivation of a tumor suppressor gene, such as p53 or INK4a, would eliminate the apoptotic pathway and allow uncontrolled growth of the mutated cell. It thus appears that, following transplacental exposure to environmental chemicals, mutation of the Ki-ras gene may be one of the earliest events, if not the actual initiating lesion, which leads to frank tumor formation, while mutagenic inactivation of the INK4a gene is a later event that occurs during tumor progression. This suggests that, in rodents, the combination of Ki-ras gene mutations and alterations in members of the Rb regulatory pathway may be the preferred pathway for tumorigenesis, both in the liver (results of this study) and the lung (17, 44, 55) . While it is generally accepted that observed mutations are directly the cause of the inducing agent, an alternative hypothesis has been proposed by Zarbl and colleagues in which the agent simply accelerates the growth of endogenously-induced tumors (56) . The experiments set forth in the present study have not definitively ruled out this possibility.
Analysis of the p53 gene did not indicate the presence of point mutations within this gene despite the well-documented role p53 plays in human carcinogenesis. This suggests that mutations of p53 may not be an important event for murine liver tumor pathogenesis. However, inactivation of p53 is often reported as a late event in tumor progression (18) ; thus, alterations in p53 may have been observed following a longer period of tumor growth in the mice. It is also possible that some of the mutations were not detected by our analysis. In support of our data, however, it has been shown that formation of liver tumors is a relatively rare occurrence in p53 knockout mice, despite the high incidence of tumors at other organ sites (57) . Several laboratories have provided confirmatory evidence that mutation of the p53 gene locus is an infrequent occurrence in mouse liver tumors and that this locus may not be as important as the INK4a locus in murine tumorigenesis (31, 55) .
The data from this study further suggest that, as shown for transplacentally-induced lung tumors (17, 44) , the metabolic phenotype had a quantitative, as opposed to a qualitative, effect on tumor incidence. All of the tumors had mutations in the Ki-ras gene locus in both responsive and non-responsive mice. Moreover, the results provide further evidence of the high sensitivity of the individual fetus to environmental toxicants, and suggest that mutagenic damage to oncogenes and tumor suppressor genes may be a critical factor mediating transplacentally-induced liver tumorigenesis. The combined results demonstrate that these mice harbor some of the same types of genetic lesions observed in human tumors, and suggest that this model is an appropriate paradigm for further studies on the pathogenesis of cancer in humans.
